Ryanair Holdings plc vs Stryker Corporation — how do they compare? Ryanair Holdings plc trades at $54.24 (market cap $27.11B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 3.9× Ryanair Holdings plc's market cap, and Ryanair Holdings plc pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Ryanair Holdings plc for 72 Days and Stryker Corporation for 21 Days on average.
| RYAAY | SYK | |
|---|---|---|
Market Cap | $27.11B | $106.24B |
Volume | 2,427,380 | 2,982,001 |
Sector | Industrials | Health |
52-Week High | $73.82 | $388.35 |
52-Week Low | $51.95 | $269.75 |
Typical Hold Time | 72 Days | 21 Days |
Enterprise Value | $24.18B | $117.70B |
Dividend Yield | 1.66% | 1.27% |
Signals from Pluang's Aura AI — not financial advice
RYAAY trades at $54.04, down 3.5% today, with technical indicators showing bearish momentum. The stock shows strong fundamentals with $13.95B revenue, 12.13% net margin, and attractive valuation at P/E 13.43. Recent earnings show mixed results with Q1 beat but Q2 miss. Analyst consensus remains positive with 65% buy ratings despite near-term headwinds from fuel costs and Boeing MAX 10 certification delays.
RYAAY presents a value opportunity with solid profitability and growth prospects, though investors face near-term risks from volatile fuel prices and operational challenges. The airline's low-cost leadership and market share gains support long-term upside, but winter capacity cuts and unhedged oil exposure require careful monitoring.
Stryker (SYK) trades at $276.97, up 0.57% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 64.98% gross margins and 14.43% net income margin, though recent Q1 2026 earnings missed expectations. Analyst consensus remains strongly bullish with 71% buy ratings and $368.11 price target, representing 33% upside potential. Recent news highlights ongoing legal investigations regarding manufacturing issues that caused an 8.8% stock drop in September 2026.
SYK presents a compelling investment case with robust fundamentals and strong analyst support, though near-term headwinds from legal scrutiny and manufacturing challenges create uncertainty. The stock's current valuation at 28.7 P/E appears reasonable given growth prospects, but investors should monitor Q3 2026 earnings results on October 29 for confirmation of business recovery from recent setbacks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →